- DeFi lending exploit drains $9.3M from More Markets, leaves reserves razor-thin
- Gilat Accepts Commitments From Israeli Investors to Participate in $100 Million Convertible Notes Offering
- India's Economy Posts Robust Growth Despite Mideast Energy Shock
- Guggenheim Adjusts Price Target on TJX Companies to $152 From $175, Keeps Buy Rating
- Bitcoin risks drop to $74,000 support after lower high, long-term outlook intact
- Ethereum price analysis: Nine-day ETF inflow streak holds ETH near $2,500
- Revolut euro stablecoin rollout hits 75 million app users in first test
- Solana market liquidation wipes out $2.2M as SOL price stalls
- PG&E Shares Fall on Bill Requiring Utilities to Pay More After Wildfires
- Eli Lilly to Pay Up to $2.875 Billion Cash for Merida Biosciences >LLY
- Third Point’s Core Scientific Stake Puts Bitcoin Miner-To-AI Trade In Focus
- August Becomes Crypto’s Best Month of 2026
- Major Canadian Economic Indicators Expected This Week
- PRECIOUS-Gold dips as Fed rate-hike bets rise, still heads for best month since January
- Cyrela says TRX, TRXF11 drop talks to buy its real estate asset portfolio
- CANADA STOCKS-TSX futures edge higher as US-Iran tensions lift oil
- High Tide to Open 3 New Canna Cabana Stores in Canada
- Pasinex Q1 FY26 net loss widens to CAD 745,023; revenue turns to CAD 223,650
- Pasinex management commentary says Q1 ended June 30, 2026 net loss widens to $745,023 on higher G&A after Horzum, Aydin Teknik consolidation
- Solana needs to hold $100, break $110.15 for a move toward $150
- Gulf Countries Invest Billions of Dollars in Building an Alternative Channel to Reduce Reliance on the Hormuz Strait
- GBP/USD Price Forecast: Finds ground slightly below 20-day EMA
- SEMPRA <SRE.N>: MIZUHO CUTS TO NEUTRAL FROM OUTPERFORM; CUTS TARGET PRICE TO $84 FROM $104
- PG&E CORP : MIZUHO CUTS TO NEUTRAL FROM OUTPERFORM; CUTS TARGET PRICE TO $16 FROM $21
- EDISON INTERNATIONAL <EIX.N>: MIZUHO CUTS TO NEUTRAL FROM OUTPERFORM; CUTS TARGET PRICE TO $70 FROM $86
- PAYPAL : MIZUHO CUTS TARGET PRICE TO $51 FROM $60
- SABRA HEALTH CARE REIT, INC. <SBRA.O>: MIZUHO RAISES TARGET PRICE TO $21 FROM $20
- Holaluz avoids license revocation as Spain closes probe over EUR 4.39 million unpaid invoices
- OMEGA HEALTHCARE INVESTORS, INC. <OHI.N>: MIZUHO RAISES TARGET PRICE TO $46 FROM $45
- Rate-Hike Odds Are Rising and the Tech Rally Looks Vulnerable -- Barrons.com
- --Aon to Buy USI Insurance Services From KKR for $17 Billion
- GameStop Expects Higher 2Q Profit, Despite Lower Sales
- Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; SELLAS Life Sciences to Advance, Tesla to Decline
- Loop Capital Adjusts Price Target on Dell Technologies to $600 From $550, Maintains Buy Rating
- DA Davidson Adjusts Price Target on Airbnb to $220 From $175, Maintains Buy Rating
- KKR expects about $3.3 billion after-tax proceeds, $2 billion adjusted net income from USI sale to Aon
- Robinhood Chain Hits Record $874.8 Million Volume — Are Meme Coins Back?
- Aon to buy USI Insurance Services in $17 billion deal
- EQB INC. <EQB.TO>: SCOTIABANK CUTS TARGET PRICE TO C$135 FROM C$141
- BeOne Medicines Reports Positive Phase 3 Survival Data for Ziihera Regimens
- GameStop to Exchange and Cancel $1.4 Billion in Convertible Notes
- Ranger Energy Services: Consideration Includes $22.5M in Cash and $5M in Equity, Based on 30-Day Trailing VWAP as of Day Prior to Closing >RNGR
- BRAVEHEART BIO, INC. <BRVE.O>: STIFEL INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $45
- Susquehanna Adjusts Price Target on IBM to $235 From $225, Keeps Neutral Rating
- Nomura Downgrades MINISO Group Holding to Neutral From Buy, Cuts Price Target to $11.70 From $18.90
- Kapsch TrafficCom shareholder proposes adding Arno Haselhorst to supervisory board at Sept. 9 meeting
- Gold Runner reports Golden Girl samples up to 25,306 g/t silver, 11.22 g/t gold in new Gold Stack trend
- Silverco Mining grants 144,792 stock options at C$ 10.5, issues 207,355 RSUs
- Aon agrees to buy USI for $17 billion
- --HC Wainwright Initiates Scribe Therapeutics at Buy With $60 Price Target
- KeyBanc Adjusts Price Target on ResMed to $267 From $255, Keeps Overweight Rating
- Zacatecas Silver Closes Final Tranche of Private Placement of Units
- Nevada King secures fourth drill rig for Atlanta gold project in Nevada
- eDreams Odigeo buys back 60,000 shares at average price EUR 5.51 under stabilization program
- Nova Minerals CEO attends US Energy Department roundtable in Alaska
- KKR agrees to sell USI Insurance Services to Aon for $17 billion
- Why Is Seeker (SKR) Price Up Today?
- Why Is the Crypto Market Down Today?
- Bitcoin, Ethereum and XRP Price Prediction: Where Prices Could Move Next
- Bunker Hill Mining intersects high-grade silver-lead-zinc mineralization at Cate-8 zone in Idaho mine
- XRP Surges 28.5% in Best August Performance Since 2021 as Spot ETFs Log $153.5M Boom
- India FQL Crypto Scam Explained: Why Guaranteed Crypto Returns Remain a Major Red Flag
- Zedge names Morris Berger CEO effective Oct. 1, Jonathan Reich to become president and COO
- Bitcoin and XRP Face Data-Heavy Week as Several US Economic Events Loom
- U.S. Political, Economic Calendar - Week Ahead
- --Keefe Bruyette & Woods Initiates River City Bank at Outperform With $58 Price Target
- IDEAYA Biosciences Plans Phase 3 Trial for Lung Cancer Therapy
- Guggenheim Downgrades Tenax Therapeutics to Neutral From Buy
- Press Release: GameStop Announces Second Quarter 2026 Preliminary Results
- BUZZ-California utilities slide after revised wildfire risk bill
- Market Chatter: US Government Plans to Take 35% Stake in North American Blue Energy Partners' Venezuelan Oil Venture
- Daiwa Securities Adjusts Price Target on Intuit to $400 From $500, Keeps Outperform Rating
- ATTOVIA THERAPEUTICS INC : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $52
- BMO Capital Adjusts PT on Mid-America Apartment Communities to $152 From $155, Keeps Outperform Rating
- Raymond James Adjusts PT on Deere & Company to $730 From $700, Keeps Outperform Rating
- Morgan Stanley Adjusts Pt on Honeywell International to $250 From $245, Maintains Equalweight Rating
- Citigroup Downgrades MINISO Group to Neutral From Buy, Adjusts Pt to $11.30 From $18.10
- Evercore ISI Adjusts PT on Rockwell Automation to $485 From $480, Maintains In Line Rating
- U.S. Treasury Yields, Dollar Retreat -- Market Talk
- Volkswagen CFO says four German sites lack economic case for future production
- Bitget PoolX to list DGrid AI (DGAI): Lock XAUT to get 83,000 DGAI airdrop
- Market View: Actual crude oil flow in the Strait of Hormuz is the core factor determining oil prices
- The main contract of Brent crude oil futures has just exceeded the $91.00 per barrel mark, now quoted at $91.01 per barrel, up 3.13% on the day.
- Brent crude oil rose by about $1 in the short term, reaching a high of $91.08 per barrel.
- Australian Dollar: RBA hike risks linger – OCBC
- Arrowhead Pharmaceuticals' Plozasiran Meets Endpoints in Studies of Patients With Severe Hypertriglyceridemia
- Duell updates financial calendar for 2027 fiscal year
- Carlin Gold names Dong Shim CFO as Aris Morfopoulos exits role
- EQT closes USD 3.2 billion Coller Capital deal
- 145.9 billion SHIB tokens enter exchanges, price risks $0.0000055 test
- Eni Enters Uruguay Offshore Sector With OFF-5 Block Agreement
- After Waller's "hawkish" remarks, the market focuses on "interest rate hikes"; Morgan Stanley: Balance sheet reduction is more likely
- Intel (INTC.US) shares rose 1.7% in pre-market trading; earlier reports indicated that SK Hynix is seeking to collaborate on chip production.
- Prostatype Genomics secures about 70% coverage for upcoming warrant exercise, targeting up to SEK 12.5 million
- SSAB steel to be used as AQS orders four more electric service vessels
- Nissan Shatai releases Integrated Report 2026
- Deufol H1 FY26 EBIT drops 39.66% to EUR 3.5 million; revenue rises 2.6% to EUR 158.9 million
- Market Chatter: SK Hynix Ponders Chip Production in Japan to Meet AI-Related Demand
- Webuy Global posts US$ 4.76 million NATAS Fair bookings, up 42% from March 2026
- Alvotech says FDA accepts AVT80 biosimilar application for review
